CVS Raises Forecast as Pharmacy Acquisitions Pad Sales

  • Pharmacy revenue offsets decline in front-of-store sales
  • Full-year adjusted earnings will be $5.81 to $5.89 a share

CVS Health Corp. beat analysts’ earnings estimates in the second quarter and raised its full-year forecast, as recent deals to add pharmacies and a nursing home drugs business helped grow revenue at the drugstore and pharmacy benefit management company.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.